Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer
Condition(s):Stage IA Non-small Cell Lung CancerLast Updated:December 6, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Stage IA Non-small Cell Lung CancerLast Updated:December 6, 2023Active, not recruiting
Condition(s):Lung CancerLast Updated:March 25, 2024Active, not recruiting
Condition(s):Lung CancerLast Updated:March 8, 2017Completed
Condition(s):Lung Neoplasms; Lymph Node ExcisionLast Updated:September 28, 2023Recruiting
Condition(s):Lung Neoplasms; SurgeryLast Updated:October 12, 2020Recruiting
Condition(s):Stage IA Non-Small Cell Lung Carcinoma; Stage IB Non-Small Cell Lung CarcinomaLast Updated:March 27, 2024Completed
Condition(s):Lung CancerLast Updated:May 30, 2017Terminated
Condition(s):Stage IA Non-small Cell Lung Cancer; Lung Carcinoid TumorLast Updated:July 16, 2020Unknown status
Condition(s):Stage IA Non-Small Cell Lung Carcinoma; Stage IB Non-Small Cell Lung CarcinomaLast Updated:February 5, 2019Terminated
Condition(s):Recurrent Non-small Cell Lung Cancer; Stage IA Non-small Cell Lung Cancer; Stage IB Non-small Cell Lung CancerLast Updated:September 16, 2015Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.